Clinic specializing in regenerative medicine|Repaircell Clinic Osaka

osaka
repaircell
clinic

Next Generation Regenerative Medicine Repair Cell Clinic Osaka

Where it's needed, it's needed.
New Regenerative Medicine: Into an Era of Differentiation and Guidance

The Ministry of Health, Labour and Welfare (MHLW) has accepted our notification of "Treatment of arthritis using autologous adipose-derived stem cells and autologous preosteoblast differentiation-inducing supernatant solution
".

*1. Cumulative total of all treatments performed at the Tokyo, Osaka, and Sapporo clinics from June 2019 to the end of January 2026.

※2. Treatment via intravenous drip

※3. 2025 Data

Click here if you are a first time user.

Click here if you are a first time user.

Experts talk about the regenerative medicine of choice
Safety and Secrets

Regenerative Medicine: A New Option for Treatment!
A professional will talk about a low-risk treatment that will return you to your original healthy body!

Why! Why choose our clinic?
The secret lies in the strength of our stem cells!
We will explain in detail about our unique culture technology.

Case Studies

We present case studies from our three clinics in Tokyo, Osaka, and Sapporo, showcasing patients who have experienced improvement in a variety of conditions, including osteoarthritis, post-stroke sequelae, and spinal cord injuries.

Utilize your own cells,
revive

What is "regenerative medicine?"

When you are injured, the wound closes, and the scar fades little by little...
It seems obvious, but that is actually the power of the cells at work.
It is your body's cells trying to become skin and bone in order to repair
the weakened parts of your body.
The treatment that maximizes the power of the cells is called
"regenerative medicine".

Features of Repair Cell Clinic Osaka

Our clinic is one of the few medical institutions in Japan that has been approved by the Ministry of Health, Labour and Welfare to provide state-of-the-art medical care using autologous cells in the fields of disease, immunology, and cosmetics.

The advanced technology of the CPC (Cell Culture Processing Center) enables the administration of stem cells in a non-refrigerated manner, resulting in a high survival rate. Since your own cells and blood are used, there is less concern about side effects such as allergies and rejection.

The Osaka Clinic offers a relaxing space where patients can receive treatment in a calm, café-like atmosphere.

  • 200 million cells can be
    administered *depending on the indication
  • High safety (no chemicals)
  • No hospitalization required
    Day trip
  • Less
    stress on the body
  • CPC with high technology
  • Relaxing
    space

Greetings from the Chairman of the Board

Sadanori Sakamoto, Chairman of the Board

Mikiyu-kai Medical Corporation

Board Chairman

Sadanori Sakamoto

Sadanori Sakamoto

What you can no longer do, to be able to do it again.

We have long been involved in community medicine for lifestyle-related diseases such as diabetes and hypertension, and joint pain such as knee and back pain, and we are realizing further possibilities by incorporating "regenerative medicine.

Osaka Clinic Director's Introduction

Toshiken Iwai, Orthopedic Surgeon

Director, Repair Cell Clinic Osaka

orthopedic surgeon

Toshiken Iwai

Toshikata Iwai

He has performed numerous surgeries (trauma, artificial joints, etc.) as an orthopedic surgeon and is currently engaged in regenerative medicine and stem cell therapy, the cutting edge of medicine that is becoming new every day.

He is a member of the Japanese Society for Regenerative Medicine, the Japanese Society of Internal Medicine, the Japanese Diabetes Association, the Japanese Neurosurgical Society, the Japanese Society for Neurosurgery, the Japanese Society for Spinal Surgery, the Japanese Orthopaedic Association, and the Chubu Society for Disaster Orthopedics, and is working to spread the latest regenerative therapies.

Microscope in use
       

Cell culture processing facility (CPC)

Collaboration with Cell Processing Center (CPC), a cell culture and processing facility essential for regenerative medicine

LICENSE

Medical institutions notified by the Ministry of Health, Labor and Welfare

Type 2 and Type 3 regenerative medicine provision plan Notified

Repair Cell Clinic submitted Type II and Type III regenerative medicine provision plans to the Ministry of Health, Labour and Welfare, which were accepted.

  • Treatment of cerebrovascular disorders using autologous adipose-derived stem cells

    Treatment of cerebrovascular disorders using autologous adipose-derived stem cells

  • Treatment of diabetes using autologous adipose-derived stem cells

    Treatment of diabetes using autologous adipose-derived stem cells

  • Treatment of liver injury using autologous adipose-derived stem cells

    Treatment of liver injury using autologous adipose-derived stem cells

  • Treatment of arthritis using autologous adipose-derived stem cells

    Treatment of arthritis using autologous adipose-derived stem cells

  • Facial atrophy and skin regeneration therapy using autologous adipose-derived stem cells

    Facial atrophy and skin regeneration therapy using autologous adipose-derived stem cells

  • Treatment of spinal cord injury using autologous adipose-derived stem cells

    Treatment of spinal cord injury using autologous adipose-derived stem cells

  • Treatment of chronic pain with autologous adipose-derived stem cells

    Treatment of chronic pain with autologous adipose-derived stem cells

  • Treatment of Osteoarthritis of the Knee with Polyplatelet Plasma (PRP)

    Treatment of Osteoarthritis with Polyplatelet Plasma (PRP)

  • Treatment of myotendonitis and ligamentitis with platelet-rich plasma (PRP)

    Treatment of myotendonitis and ligamentitis with platelet-rich plasma (PRP)

  • Skin regeneration therapy using platelet-rich plasma (PRP)

    Skin regeneration therapy using platelet-rich plasma (PRP)

  • Ministry of Health, Labour and Welfare, Committee for Regenerative Medicine|Cell therapy using activated NK cells for prevention of malignant tumors

    Cell therapy using activated NK cells for prevention of malignant tumors

  • Ministry of Health, Labour and Welfare, Committee for Regenerative Medicine|Treatment of osteoarthritis using autologous adipose-derived stem cells and autologous preosteoblast differentiation-inducing supernatant solution.

    Treatment of osteoarthritis using autologous adipose-derived stem cells and autologous preosteoblast differentiation-inducing supernatant solution.

This allows us to offer treatments that are still rarely approved in Japan, such as regenerative medicine for "osteoarthritis," in which autologous stem cells are infused into the body to regenerate internal organs, intra-articular administration of PRP (platelet-rich plasma), and skin regeneration using PRP and stem cells, as free medical services under the Act on the Safety Assurance of Regenerative Medicine, etc. Regenerative medicine using autologous stem cells is now available as an unrestricted medical procedure. Regenerative medicine using autologous stem cells is subject to strict review by a specified authorized committee for regenerative medicine approved by the Ministry of Health, Labour and Welfare (MHLW), which examines the appropriateness, safety, physician system, cell processing management system, etc., of the treatment, and only after the plan is deemed appropriate can it be submitted to the MHLW, Only then can the treatment plan be submitted to the Ministry of Health, Labour and Welfare, where it will be accepted and assigned a number.

       

Chairman Sakamoto's Blog

岩井医師のブログ

Staff Blog

Topics.

Repair Cell Clinic for Regenerative Medicine TOPtop